Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
Matsuo
T
T
Hyogo Prefectural Awaji Hospital, Sumoto, Japan.
Kario
K
K
Kodama
K
K
Okamoto
S
S
D000906:Antibodies / Q000097:blood; D020152:Antithrombin III Deficiency; D000991:Antithrombins / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D001792:Blood Platelets / Q000276:immunology; D006493:Heparin / Q000009:adverse effects; D006494:Heparin Antagonists / Q000627:therapeutic use; D006801:Humans; D010875:Pipecolic Acids / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000379:methods; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy
D000906:Antibodies; D000991:Antithrombins; D006494:Heparin Antagonists; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban